{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:23:02Z","timestamp":1789381382450,"version":"build-2803163510"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11,4]]},"DOI":"10.1097\/01.aids.0000183629.20041.bb","type":"journal-article","created":{"date-parts":[[2005,10,14]],"date-time":"2005-10-14T04:01:22Z","timestamp":1129262482000},"page":"1807-1818","source":"Crossref","is-referenced-by-count":163,"title":["Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides"],"prefix":"10.1097","volume":"19","author":[{"given":"Michael P","family":"Dub\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Tebas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven K","family":"Grinspoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Zackin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory K","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronenn","family":"Roubenoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W","family":"Shafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Wininger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally W","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Mulligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210130","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(05)63513-1","article-title":"Protease inhibitor-associated hyperglycaemia","volume":"350","author":"Dub\u00e9","year":"1997","journal-title":"Lancet"},{"key":"R2-9-20210130","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-127-10-199711150-00016","article-title":"Severe diabetes associated with protease inhibitor therapy","volume":"127","author":"Visnegarwala","year":"1997","journal-title":"Ann Intern Med"},{"key":"R3-9-20210130","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance due to HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"R4-9-20210130","doi-asserted-by":"crossref","first-page":"F167","DOI":"10.1097\/00002030-199815000-00001","article-title":"Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients","volume":"12","author":"Walli","year":"1998","journal-title":"AIDS"},{"key":"R5-9-20210130","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-199907090-00001","article-title":"Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors","volume":"13","author":"Behrens","year":"1999","journal-title":"AIDS"},{"key":"R6-9-20210130","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.CIR.100.7.700","article-title":"Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. the Swiss HIV Cohort Study","volume":"100","author":"Periard","year":"1999","journal-title":"Circulation"},{"key":"R7-9-20210130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00042560-200001010-00005","article-title":"Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection","volume":"23","author":"Mulligan","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R8-9-20210130","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1086\/317541","article-title":"Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy","volume":"32","author":"Hadigan","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R9-9-20210130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00126334-200211010-00001","article-title":"Management of metabolic complications associated with antiretroviral therapy for HIV-1 Infection: recommendations of an International AIDS Society\u2013USA Panel","volume":"31","author":"Schambelan","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-9-20210130","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/378131","article-title":"Guidelines for the evaluation and management of dyslipidemia in HIV-infected adults receiving antiretroviral therapy","volume":"37","author":"Dub\u00e9","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R11-9-20210130","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00042560-199903010-00003","article-title":"Studies of body composition and fat distribution in HIV-infected and control subjects","volume":"20","author":"Kotler","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R12-9-20210130","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00002030-199903110-00004","article-title":"Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy","volume":"13","author":"Gervasoni","year":"1999","journal-title":"AIDS"},{"key":"R13-9-20210130","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","article-title":"Clinical assessment of HIV-associated lipodystrophy in an ambulatory population","volume":"15","author":"Lichtenstein","year":"2001","journal-title":"AIDS"},{"key":"R14-9-20210130","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa030264","article-title":"Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection","volume":"349","author":"Robbins","year":"2003","journal-title":"N Engl J Med"},{"key":"R15-9-20210130","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1056\/NEJMoa030265","article-title":"Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection","volume":"349","author":"Shafer","year":"2003","journal-title":"N Engl J Med"},{"key":"R16-9-20210130","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"R17-9-20210130","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"R18-9-20210130","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2337\/diacare.20.7.1087","article-title":"The homeostasis model in the San Antonio Heart Study","volume":"20","author":"Haffner","year":"1997","journal-title":"Diabetes Care"},{"key":"R19-9-20210130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2337\/diacare.23.1.57","article-title":"Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity","volume":"23","author":"Bonora","year":"2000","journal-title":"Diabetes Care"},{"key":"R21-9-20210130","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1097\/00002030-200105040-00001","article-title":"Metabolic effects of indinavir in healthy HIV-seronegative men","volume":"15","author":"Noor","year":"2001","journal-title":"AIDS"},{"key":"R22-9-20210130","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00042560-200106010-00006","article-title":"Prospective evaluation of the effect of initiating indinavir-based therapy on insulin sensitivity and B-cell function in HIV-infected patients","volume":"27","author":"Dub\u00e9","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R23-9-20210130","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/00002030-200203290-00002","article-title":"Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: A randomized, placebo-controlled study","volume":"16","author":"Noor","year":"2002","journal-title":"AIDS"},{"key":"R24-9-20210130","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00002030-200204120-00005","article-title":"Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations","volume":"16","author":"Murata","year":"2002","journal-title":"AIDS"},{"key":"R25-9-20210130","doi-asserted-by":"crossref","first-page":"20251","DOI":"10.1074\/jbc.C000228200","article-title":"The mechanism of insulin resistance caused by HIV protease inhibitor therapy","volume":"275","author":"Murata","year":"2000","journal-title":"J Biol Chem"},{"key":"R26-9-20210130","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1086\/341489","article-title":"Prospective, 48-week, intensive metabolic study of amprenavir-based therapy","volume":"35","author":"Dub\u00e9","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R27-9-20210130","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00126334-200408150-00003","article-title":"Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV","volume":"36","author":"Squires","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R28-9-20210130","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/00002030-200411050-00005","article-title":"The effects of HIV protease inhibitors atazanavir and lopinavir\/ritonavir on insulin sensitivity in HIV-seronegative healthy adults","volume":"18","author":"Noor","year":"2004","journal-title":"AIDS"},{"key":"R29-9-20210130","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00002030-200403050-00008","article-title":"The metabolic effects of lopinavir\/ritonavir in HIV negative men","volume":"18","author":"Lee","year":"2004","journal-title":"AIDS"},{"key":"R31-9-20210130","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-121-9-199411010-00002","article-title":"Cholesterol and coronary heart disease: predicting risks by levels and ratios","volume":"121","author":"Kinosian","year":"1994","journal-title":"Ann Intern Med"},{"key":"R32-9-20210130","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/archinte.161.11.1413","article-title":"Non high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality","volume":"161","author":"Cui","year":"2001","journal-title":"Arch Intern Med"},{"key":"R33-9-20210130","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/00002030-200007070-00002","article-title":"Contribution of nucleoside analogue reverse transcripatase inhibitors to subcutaneous fat wasting in patients with HIV infection","volume":"14","author":"Mallal","year":"2000","journal-title":"AIDS"},{"key":"R34-9-20210130","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/00002030-200105040-00005","article-title":"Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection","volume":"15","author":"van der Valk","year":"2001","journal-title":"AIDS"},{"key":"R35-9-20210130","doi-asserted-by":"crossref","first-page":"41325","DOI":"10.1074\/jbc.M006474200","article-title":"Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors","volume":"275","author":"Dowell","year":"2000","journal-title":"J Biol Chem"},{"key":"R36-9-20210130","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1097\/00002030-200310170-00005","article-title":"Differential effect of HIV protease inhibitors on adipogenesis: intracellular ritonavir is not sufficient to inhibit differentiation","volume":"17","author":"Vernochet","year":"2003","journal-title":"AIDS"},{"key":"R37-9-20210130","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1097\/00002030-200311210-00005","article-title":"Some HIV protease inhibitors alter lamin A\/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation","volume":"17","author":"Caron","year":"2003","journal-title":"AIDS"},{"key":"R38-9-20210130","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1097\/00002030-200212060-00010","article-title":"Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial","volume":"16","author":"Joly","year":"2002","journal-title":"AIDS"},{"key":"R39-9-20210130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial","volume":"292","author":"Gallant","year":"2004","journal-title":"JAMA"},{"key":"R40-9-20210130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/jama.288.2.207","article-title":"Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial","volume":"288","author":"Carr","year":"2002","journal-title":"JAMA"},{"key":"R41-9-20210130","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1097\/00002030-199910220-00035","article-title":"The effects of discontinuing stavudine therapy on clinical and metabolic abnormalities in patients suffering from lipodystrophy","volume":"13","author":"Saint-Marc","year":"1999","journal-title":"AIDS"},{"key":"R42-9-20210130","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00126334-200403010-00008","article-title":"Absence of sustained hyperlactatemia in HIV-infected patients with risk factors for mitochondrial toxicity","volume":"35","author":"Wohl","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R44-9-20210130","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/00002030-200305020-00005","article-title":"Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy","volume":"17","author":"Mallon","year":"2003","journal-title":"AIDS"},{"key":"R45-9-20210130","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-M\u00f8ller","year":"2003","journal-title":"N Engl J Med"},{"key":"R46-9-20210130","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","article-title":"Cardiovascular disease risk factors in HIV patients\u2013association with antiretroviral therapy. Results from the DAD study","volume":"17","author":"Friis-M\u00f8ller","year":"2003","journal-title":"AIDS"},{"key":"R47-9-20210130","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1097\/00002030-200112070-00012","article-title":"Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy","volume":"15","author":"Duran","year":"2001","journal-title":"AIDS"},{"key":"R48-9-20210130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/sti.79.2.137","article-title":"A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals","volume":"79","author":"Power","year":"2003","journal-title":"Sex Transm Infect"},{"key":"R49-9-20210130","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1097\/00126334-200212153-00011","article-title":"Relationship between HAART adherence and adipose tissue alterations","volume":"31","author":"Ammassari","year":"2002","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.aids.0000183629.20041.bb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:55:43Z","timestamp":1785855343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200511040-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,4]]},"references-count":46,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.aids.0000183629.20041.bb","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11,4]]}}}